Baader Bank Aktiengesellschaft Matinas Bio Pharma Holdings, Inc. Transaction History
Baader Bank Aktiengesellschaft
- $1.51 Billion
- Q2 2024
A detailed history of Baader Bank Aktiengesellschaft transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 15,912 shares of MTNB stock, worth $56,805. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,912Holding current value
$56,805% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding MTNB
# of Institutions
49Shares Held
39MCall Options Held
0Put Options Held
0-
Highbridge Capital Management LLC New York, NY10.6MShares$38 Million0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.32MShares$33.3 Million0.0% of portfolio
-
Sargent Investment Group, LLC3.49MShares$12.5 Million0.12% of portfolio
-
Black Rock Inc. New York, NY2.48MShares$8.86 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.29MShares$8.18 Million0.0% of portfolio
About Matinas BioPharma Holdings, Inc.
- Ticker MTNB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,864,992
- Market Cap $774M
- Description
- Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...